1. Home
  2. ANNX vs SB Comparison

ANNX vs SB Comparison

Compare ANNX & SB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Annexon Inc.

ANNX

Annexon Inc.

SELL

Current Price

$3.96

Market Cap

873.3M

Sector

Health Care

ML Signal

SELL

Logo Safe Bulkers Inc ($0.001 par value)

SB

Safe Bulkers Inc ($0.001 par value)

SELL

Current Price

$8.62

Market Cap

773.9M

ML Signal

SELL

Company Overview

Basic Information
Metric
ANNX
SB
Founded
2011
2007
Country
United States
Monaco
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
873.3M
773.9M
IPO Year
2020
2008

Fundamental Metrics

Financial Performance
Metric
ANNX
SB
Price
$3.96
$8.62
Analyst Decision
Buy
Strong Buy
Analyst Count
10
2
Target Price
★ $15.43
$9.50
AVG Volume (30 Days)
★ 3.0M
1.4M
Earning Date
11-09-2026
11-24-2026
Dividend Yield
N/A
★ 2.81%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$16.80
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$16.77
Revenue Growth
N/A
N/A
52 Week Low
$2.54
$4.15
52 Week High
$7.18
$9.31

Technical Indicators

Market Signals
Indicator
ANNX
SB
Relative Strength Index (RSI) 40.56 51.57
Support Level $3.71 $8.02
Resistance Level $4.37 $9.19
Average True Range (ATR) 0.23 0.27
MACD 0.04 -0.02
Stochastic Oscillator 45.33 62.01

Price Performance

Historical Comparison
ANNX
SB

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

About SB Safe Bulkers Inc ($0.001 par value)

Safe Bulkers Inc is an international provider of marine drybulk transportation services, transporting bulk cargoes, particularly coal, grain, and iron ore, along international shipping routes for consumers of marine drybulk transportation services. The company employs its vessels on both period time charters and spot time charters, according to the assessment of market conditions, with consumers of marine drybulk transportation services. The company generates almost all of its revenue from Time Charters.

Share on Social Networks: